An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and to explore the
pharmacokinetics (how drugs are absorbed in the body, how they are distributed within the
body and how they are removed from the body over time) of tapentadol hydrochloride extended
release (ER) tablets in Japanese participants with moderate to severe chronic pain due to
osteoarthritis (disorder in which the joints become painful and stiff) of knee or low back
pain.